NCT06671808

HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes

HIV Infection Accompanied by Multi-Drug Resistant Tuberculosis: a Decadal Systematic Review and Meta-Analysis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 222,128 (actual)
• Sponsor: Zahedan University of Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study aims to investigate the relationship between HIV infection and multi-drug resistant tuberculosis (MDR-TB) among affected individuals in Zahedan, Iran. It will involve a detailed analysis of patient demographics, clinical characteristics, and treatment outcomes to enhance understanding of this co-infection. The findings may inform better treatment strategies and healthcare policies for managing these diseases in similar populations.

Conditions

• HIV Infection
• MDR-TB

Interventions

Type	Name	Description
OTHER	Examination of HIV Infection in Patients with Multi-Drug Resistant Tuberculosis (MDR-TB)	This meta-analysis examines the impact of HIV infection on the prevalence and outcomes of multi-drug resistant tuberculosis (MDR-TB) among affected populations. The analysis synthesizes data from multiple studies conducted across various countries, focusing on the correlation between HIV co-infection and MDR-TB rates, treatment outcomes, and demographic factors. The findings aim to enhance understanding of the complex interactions between HIV and MDR-TB, ultimately informing clinical practices and public health strategies.

Timeline

• Start date: 2024-05-15
• Primary completion: 2024-08-22
• Completion: 2024-09-03
• First posted: 2024-11-04
• Last updated: 2024-11-04

Locations

1 site across 1 country: Iran